These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8101522)

  • 1. Akathisia as EPS.
    Pearlman CA
    J Clin Psychiatry; 1993 Jul; 54(7):280. PubMed ID: 8101522
    [No Abstract]   [Full Text] [Related]  

  • 2. Complicating factors in the analysis of acute drug-induced akathisia.
    Rosebush PI; Mazurek MF
    Arch Gen Psychiatry; 1995 Oct; 52(10):878-80. PubMed ID: 7575110
    [No Abstract]   [Full Text] [Related]  

  • 3. The problem of tardive akathisia.
    Gualtieri CT
    Brain Cogn; 1993 Sep; 23(1):102-9. PubMed ID: 8105819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania.
    Nasrallah HA; Brecher M; Paulsson B
    Bipolar Disord; 2006 Oct; 8(5 Pt 1):467-74. PubMed ID: 17042884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metric characteristics of the drug-induced extrapyramidal symptoms scale (DIEPSS): a practical combined rating scale for drug-induced movement disorders.
    Kim JH; Jung HY; Kang UG; Jeong SH; Ahn YM; Byun HJ; Ha KS; Kim YS
    Mov Disord; 2002 Nov; 17(6):1354-9. PubMed ID: 12465082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Extrapyramidal effects of antipsychotic drugs].
    Kulisevsky J; Otermin P
    Neurologia; 2003 Jun; 18(5):262-8. PubMed ID: 12768512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of acute neuroleptic-induced movement disorders.
    Tonda ME; Guthrie SK
    Pharmacotherapy; 1994; 14(5):543-60. PubMed ID: 7997388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Extrapyramidal syndrome].
    Nakagawa S; Koyama T
    Ryoikibetsu Shokogun Shirizu; 2003; (38):179-82. PubMed ID: 12876960
    [No Abstract]   [Full Text] [Related]  

  • 9. Movement disorders associated with neuroleptic treatment.
    Wirshing WC
    J Clin Psychiatry; 2001; 62 Suppl 21():15-8. PubMed ID: 11584982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The present status of akathisia.
    Ayd FJ
    J Nerv Ment Dis; 1992 Mar; 180(3):208-10. PubMed ID: 1350304
    [No Abstract]   [Full Text] [Related]  

  • 11. [Akathisia--a state of agitation caused by drug].
    Lauerma H
    Duodecim; 2000; 116(13):1383-5; quiz 1385, 1415. PubMed ID: 12001361
    [No Abstract]   [Full Text] [Related]  

  • 12. Motor and mental aspects of acute extrapyramidal syndromes.
    Casey DE
    Acta Psychiatr Scand Suppl; 1994; 380():14-20. PubMed ID: 7914042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergency psychiatry: extrapyramidal side effects in the psychiatric emergency service.
    Kamin J; Manwani S; Hughes D
    Psychiatr Serv; 2000 Mar; 51(3):287-9. PubMed ID: 10686232
    [No Abstract]   [Full Text] [Related]  

  • 14. Motor and mental aspects of extrapyramidal syndromes.
    Casey DE
    Int Clin Psychopharmacol; 1995 Sep; 10 Suppl 3():105-14. PubMed ID: 8866772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurologic soft signs and olanzapine treatment in chronic schizophrenia.
    Sevincok L; Topaloglu B; Kiyilioglu N
    J Clin Psychopharmacol; 2004 Oct; 24(5):571-2. PubMed ID: 15349026
    [No Abstract]   [Full Text] [Related]  

  • 16. The continuing problem of extrapyramidal symptoms: strategies for avoidance and effective treatment.
    Gerlach J
    J Clin Psychiatry; 1999; 60 Suppl 23():20-4. PubMed ID: 10625196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case study of neuroleptic-induced akathisia: important implications for individuals with mental retardation.
    Gross EJ; Hull HG; Lytton GJ; Hill JA; Piersel WC
    Am J Ment Retard; 1993 Jul; 98(1):156-64. PubMed ID: 8103997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tardive akathisia].
    Terao T
    Ryoikibetsu Shokogun Shirizu; 2003; (38):193-5. PubMed ID: 12876963
    [No Abstract]   [Full Text] [Related]  

  • 19. The neuroleptic malignant syndrome.
    Kimsey LR; Gibbs JT; Glen RS; Markette JR; Kosted E
    Tex Med; 1983 Oct; 79(10):54-5. PubMed ID: 6138871
    [No Abstract]   [Full Text] [Related]  

  • 20. [Abnormal behavior induced by pharmaceutical products].
    Matsuo K
    Chudoku Kenkyu; 2012 Sep; 25(3):209-13. PubMed ID: 23057398
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.